<DOC>
	<DOCNO>NCT02942342</DOCNO>
	<brief_summary>The primary goal study determine prevalence undiagnosed asymptomatic coronary artery disease ( CAD ) Kalamazoo neighbor area use Coronary Computed Tomography ( CCTA ) Coronary Artery Calcium Score ( CACS ) ass asymptomatic CAD widespread enough warrant implementation CCTA routine screen tool . Additionally , study use CCTA result evaluate several method assess CAD risk asymptomatic population include Framingham Risk Score ( FRS ) Reynold 's Risk Score , Biomarkers ( High sensitivity C-Reactive Protein , Fibrinogen , Vertical Auto Profile , oxidize Low Density Lipoprotein ( LDL ) , Apolipoprotein A1 ( ApoA1 ) , Apolipoprotein B1 ( ApoB1 ) , Vitamin D , Homocysteine ) well large panel genetic marker atherosclerosis dyslipidemia .</brief_summary>
	<brief_title>Evaluation Asymptomatic Coronary Atherosclerotic Disease Among People Kalamazoo , MI</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>1 . Subject 35 55 year age . 2 . Subject receive care Kalamazoo County neighbor area . 3 . No known history coronary artery disease , peripheral vascular disease stroke . 4 . Asymptomatic per shorten World Health Organization ( WHO ) Rose Angina Questionnaire . 5 . Any one follow set clinical risk factor CAD : 1 . Premature Immediate Family History CAD ( Male &lt; 55 year old , Female &lt; 65 year old ) 2 . Diabetes Mellitus Type 2 3 . Chronic Smoker ( currently smoke least 1 cigarette per month ) 4 . Any family history CAD Dyslipidemia hypertension former smoker 6 . Stress test cardiac catheterization procedure clinically indicate subject time enrollment . 7 . Subject sign informed consent . 1 . Subject know coronary artery disease . 2 . Known abnormal stress test coronary angiography indicate . 3 . Subject unable routinely walk least 20 foot without assistance ( e.g. , require walker wheelchair mobilize known paralysis ) . 4 . Subject report active systemic cutaneous infection inflammation ( e.g. , septicemia time procedure ) . 5 . Subject uncontrolled hypertension ( &gt; 180 mmHg systolic &gt; 110mmHg diastolic ) . 6 . Subject present hemodynamic instability need emergent surgery . 7 . Known contraindication know severe reaction iodinate contrast medium . 8 . Known contraindication betablockers . 9 . Known contraindication use sublingual nitroglycerine . 10 . Subject history chronic kidney disease , Glomerular Filtration Rate ( GFR ) 45 . 11 . Subject known history NonIschemic Cardiomyopathy ( NICMP ) 12 . Subject preexist severe systemic disease illness result expect life expectancy le 2 year . 13 . Subject currently participate investigational drug another device study clinically interfere current study endpoint . 14 . Pregnant lactating subject . 15 . Known arrhythmias allow electrocardiogram ( ECG ) triggering , determine time CT scan . ECG prior procedure indicate . 16 . History brain tumor ; recent ( within past 6 month ) head brain injury , concussion , epilepsy , seizure disorder , severe liver disease , sickle cell anemia , multiple sclerosis , substance abuse , multiple myeloma , pheochromocytoma , thyroid disorder .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>